Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BOM:524661's Gross Margin % is ranked worse than 60.17% of 118
companies
in the Medical Distribution industry
Industry Median: 14.9
vs BOM:524661: 11.68
Welcure Drugs & Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Welcure Drugs & Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Welcure Drugs & Pharmaceuticals Gross Margin % Related Terms
Welcure Drugs & Pharmaceuticals Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524661 vs MCK, COR, CAH: Gross Margin % Comparison
For the Medical Distribution subindustry, Welcure Drugs & Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welcure Drugs & Pharmaceuticals Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Welcure Drugs & Pharmaceuticals's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Welcure Drugs & Pharmaceuticals's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Welcure Drugs & Pharmaceuticals (BOM:524661) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. Over the past decade, Welcure Drugs & Pharmaceuticals' Gross Margin % has ranged from 11.68 to 16.48. According to the industry distribution chart, Welcure Drugs & Pharmaceuticals ranks #71 out of 118 companies in the Medical Distribution industry, placing it in the top 60.2%.
Is Welcure Drugs & Pharmaceuticals' Gross Margin % too high?
Welcure Drugs & Pharmaceuticals' current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 11.68 to a high of 16.48. Based on the distribution chart, Welcure Drugs & Pharmaceuticals ranks #71 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Welcure Drugs & Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Welcure Drugs & Pharmaceuticals' Gross Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Welcure Drugs & Pharmaceuticals ranks #71 out of 118 companies for Gross Margin %. This places Welcure Drugs & Pharmaceuticals in the lower half of its industry. The industry median Gross Margin % is 14.90. Historically, Welcure Drugs & Pharmaceuticals' own Gross Margin % has ranged from 11.68 to 16.48 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.90, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welcure Drugs & Pharmaceuticals's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcure Drugs & Pharmaceuticals stock overvalued right now?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Welcure Drugs & Pharmaceuticals' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Welcure Drugs & Pharmaceuticals (BOM:524661), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Welcure Drugs & Pharmaceuticals Business Description
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
19GF Score
Get the complete analysis for BOM:524661
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524661 has been successfully added to your 
